ST. LOUIS–(BUSINESS WIRE)–Reinsurance Group of America, Incorporated (NYSE: RGA) (the “Company”) announced today that it…
Milestone highlights quality commitment of physicians and practices CHICAGO–(BUSINESS WIRE)–The Society for Vascular Surgery® Vascular…
Joining X1’s C-Suite will be Abhi Pabba, previously Apple Card’s head of credit, and Kieran…
Appoints Brian Lenihan vice president of government relations to build upon SkyWater’s strategic initiatives in…
Leader in Edge-to-Cloud Applications Expands Its Intellectual Property Portfolio With Solution to Optimize How Event-Driven…
Over 150 Tech Startups Applied for Spots at Miami Conference in December Which Will Bring…
The PIC32CM JH microcontroller is a 512KB Flash, 5V, Dual CAN FD device that delivers…
Sorrento has now completed its first Phase 1b human proof of concept study where the…
Balance Sheet Remains Strong, Despite Slow Economic Recovery TORONTO, Sept. 15, 2022 (GLOBE NEWSWIRE) —…
New York, NY, and Tel Aviv, ISRAEL, Sept. 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire…
Executive brings more than 30 years of global biopharmaceutical operations and program management experience MIAMI,…
CARLSBAD, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage…
MORRISVILLE, N.C., Sept. 15, 2022 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty…
110 Patients Enrolled in Study Comparing Novel Gene-Mediated Immunotherapy plus Neoadjuvant Chemotherapy versus Neoadjuvant Chemotherapy…
– Scientific collaborators at Stanford University will present data on an imaging and treatment regimen…
NEEDHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL) (Candel or…
– New data analysis from previously completed successful Phase 3 study1 demonstrated WYNZORA® Cream to…
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a…
Newly formed company founded by prominent Yale professors will advance development of novel RNA therapies…
JSP191 is currently being evaluated in four ongoing clinical studies in allogeneic hematopoietic stem cell…